BiotechTube
Home/Sanara MedTech/Nicholas Gachassin, III
NG

Nicholas Gachassin, III

General Counsel

Sanara MedTech

Therapeutic Areas

Surgical/Wound ManagementOrthopedic TraumaBone Repair

Sanara MedTech Pipeline

DrugIndicationPhase
CellerateRX® GelSurgical/Wound ManagementApproved/Commercial
CellerateRX® Surgical PowderSurgical/Wound ManagementApproved/Commercial
BIASURGE® Advanced Surgical SolutionSurgical IrrigationApproved/Commercial
FORTIFY TRG® Tissue Repair GraftSoft Tissue RepairApproved/Commercial
FORTIFY FLOWABLE® Extracellular MatrixSoft Tissue RepairApproved/Commercial
TEXAGEN® Amniotic Membrane AllograftWound and Surgical RepairApproved/Commercial
ALLOCYTE® Plus Advanced Viable Bone MatrixBone GraftingApproved/Commercial
BiFORM® Bioactive Moldable MatrixBone Void FillingApproved/Commercial

Leadership Team at Sanara MedTech

RB
Robert Bearden
Senior Vice President, Clinical and Medical Affairs
NB
Nina Bionda
Chief R&D Officer
TP
Tyler Palmer
Chief Corporate Development and Strategy Officer
BD
Bob DeSutter
Director
RM
Roszell Mack III
Director
EM
Eric Major
Director
View full Sanara MedTech profile